The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model
Open accessAbstract
OBJECTIVES: To compare patient outcomes, resource use and costs to the NHS and NHS Blood Transfusion Authority (BTA) associated with cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion. DATA SOURCES: Electronic databases covering the period 1996-2004 for systematic reviews and 1994-2004 for economic evidence. REVIEW METHODS: Existing systematic reviews were updated with data from selected randomised controlled trials (RCTs) that involved adults scheduled for elective non-urgent surgery. Any resource use or cost data were extracted for potential use in populating an economic model. Relative risks or weighted mean difference of each outcome for each intervention were assessed, taking into account the number of RCTs included in each outcome and intervention and the presence of any heterogeneity. This allowed indirect comparison of the relative effectiveness of each intervention when the intervention is compared with allogeneic blood transfusion. A decision analytic model synthesised clinical and economic data from several sources, to estimate the relative cost-effectiveness of cell salvage for people undergoing elective surgery with moderate to major expected blood loss. The perspective of the NHS and patients and a time horizon of 1 month were used. The economic model was developed from reviews of effectiveness and cost-effectiveness and clinical experts. Secondary analysis explored the robustness of the results to changes in the timing and costs of cell salvage equipment, surgical procedure, use of transfusion protocols and time horizon of analysis. RESULTS: Overall, 668 studies were identified electronically for the update of the two systematic reviews. This included five RCTs, of which two were cell salvage and three preoperative autologous donation (PAD). Five published systematic reviews were identified for antifibrinolytics, fibrin sealants and restrictive transfusion triggers, PAD plus erythropoietin, erythropoietin alone and acute normovolaemic haemodilution (ANH). Twelve published studies reported full economic evaluations. All but two of the transfusion strategies significantly reduced exposure to allogeneic blood. The relative risk of exposure to allogeneic blood was 0.59 for the pooled trials of cell salvage (95% confidence interval: 0.48 to 0.73). This varied by the type and timing of cell salvage and type of surgical procedure. For cell salvage, the relative risk of allogeneic blood transfusion was higher in cardiac surgery than in orthopaedic surgery. Cell salvage had lower costs and slightly higher quality-adjusted life years compared with all of the alternative transfusion strategies except ANH. The likelihood that cell salvage is cost-effective compared with strategies other than ANH is over 50%. Most of the secondary analyses indicated similar results to the primary analysis. However, the primary and secondary analyses indicated that ANH may be more cost-effective than cell salvage. CONCLUSIONS: The available evidence indicates that cell salvage may be a cost-effective method to reduce exposure to allogeneic blood transfusion. However, ANH may be more cost-effective than cell salvage. The results of this analysis are subject to the low quality and reliability of the data used and the use of indirect comparisons. This may affect the reliability and robustness of the clinical and economic results. There is a need for further research that includes adequately powered high-quality RCTs to compare directly various blood transfusion strategies. These should include measures of health status, health-related quality of life and patient preferences for alternative transfusion strategies. Observational and tracking studies are needed to estimate reliably the incidence of adverse events and infections transmitted during blood transfusion and to identify the lifetime consequences of the serious hazards of transfusion on mortality, health status and health-related quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
Avenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041
Self-citation
Cited by
Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology
Kozek-Langenecker, S. A., Afshari, A., Albaladejo, P., Santullano, C. A. A., De Robertis, E., Filipescu, D. C., Fries, D., Görlinger, K., Haas, T., Imberger, G., et al. (2013) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32835f4d5b · Cited by 909
Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care*
Napolitano, L. M., Kurek, S., Luchette, F. A., Corwin, H. L., Barie, P. S., Tisherman, S. A., Hebert, P. C., Anderson, G. L., Bard, M. R., Bromberg, W., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b39f1b · Cited by 551
Cell salvage for minimising perioperative allogeneic blood transfusion
Carless, P. A., Henry, D. A., Moxey, A. J., O’Connell, D. L., Brown, T. J., & Fergusson, D. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001888.pub4 · Cited by 462
Self-citationWhiting, P., Al, M., Westwood, M., Ramos, I. C., Ryder, S., Armstrong, N., Misso, K., Ross, J., Severens, J., & Kleijnen, J. (2015) · Health Technology Assessment · doi:10.3310/hta19580 · Cited by 310
Barton, G. R., Briggs, A. H., & Fenwick, E. A. L. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00358.x · Cited by 290
Cell salvage as part of a blood conservation strategy in anaesthesia
Ashworth, A., & Klein, A. A. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq244 · Cited by 286
Accuracy of teledermatology for pigmented neoplasms
Warshaw, E. M., Lederle, F. A., Grill, J. P., Gravely, A. A., Bangerter, A. K., Fortier, L. A., Bohjanen, K. A., Chen, K., Lee, P. K., Rabinovitz, H. S., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.04.032 · Cited by 175
Teledermatology: Key factors associated with reducing face-to-face dermatology visits
Landow, S. M., Mateus, A., Korgavkar, K., Nightingale, D., & Weinstock, M. A. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.02.021 · Cited by 131
Teledermatology: A Review of Reliability and Accuracy of Diagnosis and Management
S. Levin, Y., & Warshaw, E. M. (2009) · Dermatologic Clinics · doi:10.1016/j.det.2008.11.012 · Cited by 92
The impact of store-and-forward teledermatology on skin cancer diagnosis and treatment
Hsiao, J. L., & Oh, D. H. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.04.011 · Cited by 68
McFarland, L. V., Raugi, G. J., & Reiber, G. E. (2013) · Telemedicine and e-Health · doi:10.1089/tmj.2012.0327 · Cited by 48
Marchell, R., Locatis, C., Burges, G., Maisiak, R., Liu, W.-L., & Ackerman, M. (2017) · Telemedicine and e-Health · doi:10.1089/tmj.2016.0093 · Cited by 37
Ford, J. A., & Pereira, A. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12373 · Cited by 34
Telemedicina y teledermatología (II)
Romero, G., Cortina, P., & Vera, E. (2008) · Actas Dermo-Sifiliográficas · doi:10.1016/s0001-7310(08)74755-0 · Cited by 22
Metadata
- Authors
- Davies, L., Brown, T., Haynes, S., Payne, K., Elliott, R., & McCollum, C.
- Venue
- Health Technology Assessment
- Published
- 2006-11
- Volume
- 10
- Issue
- 44
- Pages
- iii-iv, ix
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2042458140
- Cited by
- 215
- References
- 2
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.